Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:666880rdf:typepubmed:Citationlld:pubmed
pubmed-article:666880lifeskim:mentionsumls-concept:C0014507lld:lifeskim
pubmed-article:666880lifeskim:mentionsumls-concept:C0024141lld:lifeskim
pubmed-article:666880lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:666880pubmed:issue5 Suppllld:pubmed
pubmed-article:666880pubmed:dateCreated1978-8-14lld:pubmed
pubmed-article:666880pubmed:abstractTextLymphocytotoxic antibodies (LCTA) occur in 80% of SLE patients and 40% to 60% of their asymptomatic relatives. They occur equally in consanguineous and nonconsanguineous relatives, are more common with close proband contact, and vary directly with LCTA activity in the proband. LCTA are also increased in laboratory personnel handling SLE blood. Anti-RNA antibodies are found in SLE patients and consanguineous relatives. Both antibodies are primarily IgM in relatives but are IgM and IgG in SLE patients.lld:pubmed
pubmed-article:666880pubmed:languageenglld:pubmed
pubmed-article:666880pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:666880pubmed:citationSubsetAIMlld:pubmed
pubmed-article:666880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:666880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:666880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:666880pubmed:statusMEDLINElld:pubmed
pubmed-article:666880pubmed:monthJunlld:pubmed
pubmed-article:666880pubmed:issn0004-3591lld:pubmed
pubmed-article:666880pubmed:authorpubmed-author:MessnerR PRPlld:pubmed
pubmed-article:666880pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:666880pubmed:issnTypePrintlld:pubmed
pubmed-article:666880pubmed:volume21lld:pubmed
pubmed-article:666880pubmed:ownerNLMlld:pubmed
pubmed-article:666880pubmed:authorsCompleteYlld:pubmed
pubmed-article:666880pubmed:paginationS167-70lld:pubmed
pubmed-article:666880pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-H...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-L...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-L...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-C...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-A...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-I...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-I...lld:pubmed
pubmed-article:666880pubmed:meshHeadingpubmed-meshheading:666880-C...lld:pubmed
pubmed-article:666880pubmed:year1978lld:pubmed
pubmed-article:666880pubmed:articleTitleEpidemiology of anti-lymphocyte antibodies in systemic lupus erythematosus.lld:pubmed
pubmed-article:666880pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:666880pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:666880lld:pubmed